Fibovil Pharmaceuticals Pvt Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Voglivil 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults.
Tablet
Voglivil 2mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Voglivil 2mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Voglivil 2mg/500mg/0.2mg Tablet.
Voglivil 2mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Voglivil 2mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby.
Voglivil 2mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Voglivil 2mg/500mg/0.2mg Tablet is a combination medication containing Glimepiride, Metformin and Voglibose, used to treat type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken with a proper diet and regular exercise. Glimepiride lowers blood glucose levels by increasing insulin release from the pancreas. Metformin works by reducing glucose production in the liver and improving insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that lowers postprandial (after meal) glucose levels.
Common side effects associated with Voglivil 2mg/500mg/0.2mg Tablet include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
The use of Voglivil 2mg/500mg/0.2mg Tablet should be avoided in patients with known allergies to any components or excipients of this medication. It is also unsuitable for individuals with moderate to severe kidney disease and those with inflammatory bowel disease, colonic ulcers, and underlying metabolic acidosis, including diabetic ketoacidosis.
No, combining Voglivil 2mg/500mg/0.2mg Tablet with alcohol is not recommended as this may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, the use of Voglivil 2mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate and feeling anxious or shaky. This risk is higher if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications along with this treatment. Regular monitoring of blood sugar levels is important.
Store Voglivil 2mg/500mg/0.2mg Tablet in its original packaging, tightly sealed. Follow the storage instructions on the product label. Do not share this medicine with others. Ensure that pets, children, and other individuals do not consume it.